BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2429095)

  • 1. Interaction between nifedipine and atenolol: pharmacokinetics and pharmacodynamics in normotensive volunteers.
    Rosenkranz B; Ledermann H; Frölich JC
    J Cardiovasc Pharmacol; 1986; 8(5):943-9. PubMed ID: 2429095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the cardiovascular effects of nifedipine and nicardipine in the presence of atenolol.
    Thomas SH
    Eur J Clin Pharmacol; 1991; 41(3):201-6. PubMed ID: 1748136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the pharmacokinetics and pharmacodynamics of nifedipine in combination with atenolol.
    Fitzsimons TJ; Norris SC; Adam HK; Ryan J; McAinsh J
    Biopharm Drug Dispos; 1991; 12(1):81-94. PubMed ID: 2039814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the combination of alinidine and other anti-anginal drugs on heart rate and blood pressure in healthy volunteers.
    Harron DW; Deering AH; Scott M; McMahon M; Shanks RG
    Br J Clin Pharmacol; 1989 Jan; 27(1):23-9. PubMed ID: 2495813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of calcium antagonists on ambulatory blood pressure and its variations.
    Clement DL; De Pue NY; Packet L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S117-9. PubMed ID: 2455109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
    Gangji D; Juvent M; Niset G; Wathieu M; Degreve M; Bellens R; Poortmans J; Degre S; Fitzsimons TJ; Herchuelz A
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of antihypertensive medications on the physiological response to maximal exercise testing.
    Derman WE; Sims R; Noakes TD
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S122-7. PubMed ID: 1381788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris.
    Wallace WA; Wellington KL; Chess MA; Liang CS
    Am J Cardiol; 1994 Jan; 73(1):23-8. PubMed ID: 8279372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of atenolol and nifedipine on digoxin-induced inotropism in humans.
    Hansen PB; Buch J; Rasmussen OO; Waldorff S; Steiness E
    Br J Clin Pharmacol; 1984 Dec; 18(6):817-22. PubMed ID: 6529522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men.
    Vanhees L; Defoor JG; Schepers D; Lijnen P; Peeters BY; Lacante PH; Fagard RH
    J Hypertens; 2000 Jan; 18(1):35-43. PubMed ID: 10678541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
    Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
    Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combined atenolol and nifedipine administration on psychomotor performance in normal subjects.
    Gerrard L; Wheeldon NM; McDevitt DG
    Eur J Clin Pharmacol; 1995; 48(3-4):229-33. PubMed ID: 7589046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute response to submaximal and maximal exercise consequent to beta-adrenergic blockade: implications for the prescription of exercise.
    Wilmore JH; Freund BJ; Joyner MJ; Hetrick GA; Hartzell AA; Strother RT; Ewy GA; Faris WE
    Am J Cardiol; 1985 Apr; 55(10):135D-141D. PubMed ID: 3993545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Nifedipine-Atenolol Study Review Committee.
    Nifedipine-Atenolol Study Review Committee
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):468-72. PubMed ID: 2894883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of racemic and S(-)-atenolol in humans.
    McCoy RA; Clifton GD; Clementi WA; Smith MD; Garvey TQ; Wermeling DP; Schwartz SE
    J Clin Pharmacol; 1994 Aug; 34(8):816-22. PubMed ID: 7962669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease.
    Donaldson KM; Dawkins KD; Waller DG
    Br J Clin Pharmacol; 1993 Oct; 36(4):315-21. PubMed ID: 12959309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atenolol on rest and exercise hemodynamics in patients with mitral stenosis.
    Stoll BC; Ashcom TL; Johns JP; Johnson JE; Rubal BJ
    Am J Cardiol; 1995 Mar; 75(7):482-4. PubMed ID: 7863993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol.
    Rowland E; Razis P; Sugrue D; Krikler DM
    Br Heart J; 1983 Oct; 50(4):383-9. PubMed ID: 6354228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone.
    Daniels AR; Opie LH
    Am J Cardiol; 1986 Apr; 57(11):965-70. PubMed ID: 3515899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atenolol-nifedipine combinations compared to atenolol alone in hypertension: efficacy and tolerability.
    Maclean D; Mitchell ET; Coulson RR; Fitzsimons TJ; McDevitt DG
    Br J Clin Pharmacol; 1988 Apr; 25(4):425-31. PubMed ID: 3289598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.